U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H35F3N4O5S.C7H8O3S
Molecular Weight 816.906
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-7295 TOSYLATE

SMILES

CC1=CC=C(C=C1)S(O)(=O)=O.CCCS(=O)(=O)N2CCN(CC3=CC=C(NC(=O)C4=CC=C(C=C4)C5=CC(NC(=O)C6CC6)=CC=C5OC(F)(F)F)C=C3)CC2

InChI

InChIKey=LLZXGLMVVXUEOP-UHFFFAOYSA-N
InChI=1S/C32H35F3N4O5S.C7H8O3S/c1-2-19-45(42,43)39-17-15-38(16-18-39)21-22-3-11-26(12-4-22)36-30(40)24-7-5-23(6-8-24)28-20-27(37-31(41)25-9-10-25)13-14-29(28)44-32(33,34)35;1-6-2-4-7(5-3-6)11(8,9)10/h3-8,11-14,20,25H,2,9-10,15-19,21H2,1H3,(H,36,40)(H,37,41);2-5H,1H3,(H,8,9,10)

HIDE SMILES / InChI

Molecular Formula C7H8O3S
Molecular Weight 172.202
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C32H35F3N4O5S
Molecular Weight 644.704
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

A-689 (AZD-7295) was the lead compound from Arrow Therapeutics' second series of hepatitis C virus (HCV) NS5a inhibitors. AZD-7295 is a selective inhibitor of HCV NS5A within vitroantiviral activity of 7nM and 1.24mM against HCV genotype1b and 1a replicons respectively, with significant liver concentrationin preclinical studies. AZD-7295 was well tolerated at repeated doses ofup to 700 mg daily. AZD-7295 shows potent antiviral activity ingenotype 1b patients. Genotype 1a and genotype 3 patients showedno antiviral effects.

Approval Year

PubMed

PubMed

TitleDatePubMed
Current race in the development of DAAs (direct-acting antivirals) against HCV.
2014-06-15
Patents

Sample Use Guides

700mg per day maximum
Route of Administration: Oral
AZD-7295 is a selective inhibitor of HCV NS5A within vitroantiviral activity of 7nM and 1.24mM against HCV genotype1b and 1a replicons respectively, with significant liver concentrationin preclinical studies.
Substance Class Chemical
Created
by admin
on Wed Apr 02 19:14:19 GMT 2025
Edited
by admin
on Wed Apr 02 19:14:19 GMT 2025
Record UNII
5SQP3W5X7K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD7259 TOSYLATE
Preferred Name English
AZD-7295 TOSYLATE
Common Name English
[1,1?-Biphenyl]-4-carboxamide, 5?-[(cyclopropylcarbonyl)amino]-N-[4-[[4-(propylsulfonyl)-1-piperazinyl]methyl]phenyl]-2?-(trifluoromethoxy)-, tosylate
Systematic Name English
Code System Code Type Description
FDA UNII
5SQP3W5X7K
Created by admin on Wed Apr 02 19:14:19 GMT 2025 , Edited by admin on Wed Apr 02 19:14:19 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY